Swiss National Bank Acquires 70,300 Shares of Danaher Co. (NYSE:DHR)

Swiss National Bank increased its stake in shares of Danaher Co. (NYSE:DHR) by 2.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,532,844 shares of the conglomerate’s stock after buying an additional 70,300 shares during the quarter. Swiss National Bank owned about 0.35% of Danaher worth $334,386,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. Norges Bank bought a new position in shares of Danaher in the 4th quarter valued at $747,082,000. Oregon Public Employees Retirement Fund lifted its stake in shares of Danaher by 10,085.3% in the 4th quarter. Oregon Public Employees Retirement Fund now owns 6,863,048 shares of the conglomerate’s stock valued at $67,000 after acquiring an additional 6,795,666 shares during the last quarter. Findlay Park Partners LLP lifted its stake in shares of Danaher by 25.0% in the 4th quarter. Findlay Park Partners LLP now owns 4,595,000 shares of the conglomerate’s stock valued at $473,836,000 after acquiring an additional 920,000 shares during the last quarter. 1832 Asset Management L.P. lifted its stake in shares of Danaher by 74.3% in the 4th quarter. 1832 Asset Management L.P. now owns 2,129,142 shares of the conglomerate’s stock valued at $219,310,000 after acquiring an additional 907,593 shares during the last quarter. Finally, Polar Capital LLP raised its position in Danaher by 678.1% during the 4th quarter. Polar Capital LLP now owns 744,570 shares of the conglomerate’s stock worth $76,780,000 after purchasing an additional 648,885 shares during the last quarter. 78.82% of the stock is currently owned by institutional investors and hedge funds.

In related news, Director Alan G. Spoon sold 1,913 shares of Danaher stock in a transaction that occurred on Wednesday, April 24th. The shares were sold at an average price of $129.52, for a total value of $247,771.76. Following the sale, the director now owns 86,863 shares of the company’s stock, valued at approximately $11,250,495.76. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Donald J. Ehrlich sold 5,000 shares of Danaher stock in a transaction that occurred on Thursday, May 16th. The stock was sold at an average price of $132.95, for a total transaction of $664,750.00. Following the completion of the sale, the director now directly owns 100,603 shares in the company, valued at approximately $13,375,168.85. The disclosure for this sale can be found here. In the last three months, insiders have sold 453,448 shares of company stock worth $59,724,640. Insiders own 11.40% of the company’s stock.

Several research analysts recently issued reports on the company. Zacks Investment Research lowered Danaher from a “hold” rating to a “sell” rating in a research report on Tuesday, April 30th. Janney Montgomery Scott lifted their price objective on Danaher from $136.00 to $174.00 and gave the stock a “buy” rating in a research report on Wednesday, April 17th. Wolfe Research assumed coverage on Danaher in a research report on Thursday, May 30th. They issued an “outperform” rating for the company. JPMorgan Chase & Co. reissued an “overweight” rating and issued a $140.00 price objective on shares of Danaher in a research report on Monday, March 4th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $138.00 price objective (up from $114.00) on shares of Danaher in a research report on Thursday, February 28th. Three research analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. Danaher has an average rating of “Buy” and an average price target of $133.00.

Shares of DHR traded up $0.87 during trading hours on Friday, hitting $142.85. The stock had a trading volume of 3,777,800 shares, compared to its average volume of 2,698,431. The firm has a market cap of $101.41 billion, a price-to-earnings ratio of 31.60, a P/E/G ratio of 2.72 and a beta of 0.95. The company has a quick ratio of 1.74, a current ratio of 2.18 and a debt-to-equity ratio of 0.32. Danaher Co. has a 1-year low of $94.59 and a 1-year high of $144.57. The business’s 50 day moving average is $135.57.

Danaher (NYSE:DHR) last released its quarterly earnings results on Thursday, April 18th. The conglomerate reported $1.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.01 by $0.06. Danaher had a return on equity of 11.61% and a net margin of 12.04%. The business had revenue of $4.88 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same quarter in the previous year, the business earned $0.99 EPS. The company’s quarterly revenue was up 3.9% on a year-over-year basis. On average, research analysts forecast that Danaher Co. will post 4.77 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, July 26th. Shareholders of record on Friday, June 28th will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, June 27th. This represents a $0.68 annualized dividend and a dividend yield of 0.48%. Danaher’s dividend payout ratio is currently 15.04%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

Read More: What is the Ex-Dividend Date in Investing?

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.